Syntara Ltd (SNT) - Total Assets

Latest as of June 2025: AU$21.44 Million AUD ≈ $15.17 Million USD

Based on the latest financial reports, Syntara Ltd (SNT) holds total assets worth AU$21.44 Million AUD (≈ $15.17 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Syntara Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Syntara Ltd - Total Assets Trend (2003–2025)

This chart illustrates how Syntara Ltd's total assets have evolved over time, based on quarterly financial data. Check Syntara Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Syntara Ltd - Asset Composition Analysis

Current Asset Composition (June 2025)

Syntara Ltd's total assets of AU$21.44 Million consist of 97.8% current assets and 2.2% non-current assets.

Asset Category	Amount (AUD)	% of Total Assets
Cash & Equivalents	AU$0.00	70.3%
Accounts Receivable	AU$5.66 Million	26.4%
Inventory	AU$0.00	0.0%
Property, Plant & Equipment	AU$180.00K	0.8%
Intangible Assets	AU$149.00K	0.7%
Goodwill	AU$0.00	0.0%

Asset Composition Trend (2003–2025)

This chart illustrates how Syntara Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Syntara Ltd market capitalisation.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Syntara Ltd's current assets represent 97.8% of total assets in 2025, an increase from 90.1% in 2003.
Cash Position: Cash and equivalents constituted 70.3% of total assets in 2025, down from 89.6% in 2003.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 4.0% in 2003.
Asset Diversification: The largest asset category is accounts receivable at 26.4% of total assets.

Syntara Ltd Competitors by Total Assets

Key competitors of Syntara Ltd based on total assets are shown below.

Company	Country	Total Assets
Tasly Pharmaceutical Group Co Ltd SHG:600535	China	CN¥15.69 Billion
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	China	CN¥5.17 Billion
Shanghai Haoyuan Chemexpress Co. Ltd. A SHG:688131	China	CN¥6.49 Billion
Bausch Health Companies Inc TO:BHC	Canada	CA$24.50 Billion
Dezhan HealthCare Co Ltd SHE:000813	China	CN¥4.80 Billion
Guizhou Xinbang Pharmaceutical Co Ltd SHE:002390	China	CN¥8.59 Billion
Hainan Haiyao Co Ltd SHE:000566	China	CN¥5.79 Billion
Shanxi Zhendong Pharmaceutical SHE:300158	China	CN¥4.51 Billion

Syntara Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	3.93	1.79	3.59
Quick Ratio	3.93	1.79	3.20
Cash Ratio	0.00	0.00	0.00
Working Capital	AU$15.63 Million	AU$4.32 Million	AU$17.67 Million

Syntara Ltd - Advanced Valuation Insights

This section examines the relationship between Syntara Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	3.26
Latest Market Cap to Assets Ratio	1.35
Asset Growth Rate (YoY)	106.6%
Total Assets	AU$21.44 Million
Market Capitalization	$28.89 Million USD

Valuation Analysis

Above Book Valuation: The market values Syntara Ltd's assets above their book value (1.35x), reflecting positive investor sentiment about the company's future prospects.

Rapid Asset Growth: Syntara Ltd's assets grew by 106.6% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Syntara Ltd (2003–2025)

The table below shows the annual total assets of Syntara Ltd from 2003 to 2025.

Year	Total Assets	Change
2025-06-30	AU$21.44 Million ≈ $15.17 Million	+106.56%
2024-06-30	AU$10.38 Million ≈ $7.35 Million	-56.79%
2023-06-30	AU$24.03 Million ≈ $17.00 Million	-4.61%
2022-06-30	AU$25.19 Million ≈ $17.82 Million	-25.02%
2021-06-30	AU$33.59 Million ≈ $23.77 Million	-5.16%
2020-06-30	AU$35.42 Million ≈ $25.06 Million	-32.76%
2019-06-30	AU$52.67 Million ≈ $37.27 Million	+5.13%
2018-06-30	AU$50.10 Million ≈ $35.45 Million	+10.26%
2017-06-30	AU$45.43 Million ≈ $32.15 Million	-30.80%
2016-06-30	AU$65.65 Million ≈ $46.45 Million	-20.48%
2015-06-30	AU$82.56 Million ≈ $58.42 Million	+23.69%
2014-06-30	AU$66.75 Million ≈ $47.23 Million	-40.55%
2013-06-30	AU$112.28 Million ≈ $79.45 Million	-14.75%
2012-06-30	AU$131.70 Million ≈ $93.19 Million	+39.26%
2011-06-30	AU$94.57 Million ≈ $66.92 Million	-32.82%
2010-06-30	AU$140.77 Million ≈ $99.60 Million	-14.16%
2009-06-30	AU$164.00 Million ≈ $116.04 Million	+31.15%
2008-06-30	AU$125.05 Million ≈ $88.48 Million	+51.30%
2007-06-30	AU$82.65 Million ≈ $58.48 Million	-20.73%
2006-06-30	AU$104.27 Million ≈ $73.78 Million	+174.84%
2005-06-30	AU$37.94 Million ≈ $26.84 Million	+34.24%
2004-06-30	AU$28.26 Million ≈ $20.00 Million	-5.15%
2003-06-30	AU$29.79 Million ≈ $21.08 Million	--

About Syntara Ltd

AU:SNT Australia Drug Manufacturers - Specialty & Generic

Market Cap

$28.89 Million

AU$40.83 Million AUD

Market Cap Rank

#23929 Global

#943 in Australia

Share Price

AU$0.03

Change (1 day)

+4.17%

52-Week Range

AU$0.02 - AU$0.06

All Time High

AU$0.40